EKF Diagnostics (LON:EKF – Get Free Report) released its earnings results on Tuesday. The company reported GBX 0.54 EPS for the quarter, Digital Look Earnings reports. EKF Diagnostics had a return on equity of 3.58% and a net margin of 4.86%.
EKF Diagnostics Stock Performance
EKF stock traded up GBX 0.10 during mid-day trading on Thursday, hitting GBX 25.10. The company had a trading volume of 69,255 shares, compared to its average volume of 324,992. The company has a debt-to-equity ratio of 2.09, a quick ratio of 1.77 and a current ratio of 4.72. The firm has a market cap of £107.47 million, a PE ratio of 53.40 and a beta of 0.50. EKF Diagnostics has a 12 month low of GBX 22 and a 12 month high of GBX 31.70. The stock’s fifty day moving average price is GBX 25.43 and its two-hundred day moving average price is GBX 25.51.
EKF Diagnostics Company Profile
● Point-of-Care analysers in the key areas of Hematology and Diabetes
● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
Featured Articles
- Five stocks we like better than EKF Diagnostics
- Can ServisFirst Keep Delivering?
- CoreWeave’s Vera Rubin Lead Comes Down to Speed, Power, and Scale
- Micron’s New 512GB Memory Module Deepens Its AI Infrastructure Advantage
- Banc of California Bets on Short-Term Pain
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
